CClinicalTrials.gg
CompletedNCT04863846Expect-itUpdated Mar 2, 2022

Evidence-based Algorithm for the Expected Difficult Intubation

An observational study in Airway Management and Intubation, Intratracheal, sponsored by Universitätsklinikum Hamburg-Eppendorf. Completed at 1 site in Germany. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2022-03-02.

Sponsored by Universitätsklinikum Hamburg-Eppendorf · Observational

Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
1,282
Ages
18 Years and older
Sex
All
01

Study summary

The Expect-it study aims to accompany the development and clinical implementation process of a new algorithm for the management of expected difficult intubation. The new algorithm is designed to allocate patients to specific tracheal intubation techniques. After assessing the status quo (non-algorithm-based decision-making) the new algorithm-based allocation will be compared with this clinical standard within a confirmatory diagnostic accuracy study (post-implementation).

Read the detailed description

Difficult tracheal intubation is one of the major reasons for anesthesia-related adverse events. Patients undergoing ear, nose \& throat (ENT) or oral and maxillofacial (OMS) surgery often require tracheal intubation for general anesthesia but are at increased risk for difficult tracheal intubation. Currently, existing preoperative tests for the prediction of difficult intubation show low diagnostic accuracy. Moreover, as the results of these prediction tests are not coupled with concrete treatment recommendations, they cannot be used targeted within preventive concepts. An evidence based rational algorithm for the management of expected difficult intubation has not been developed yet. It is unknown, if an algorithm-based allocation to an intubation approach might be advantageous compared with a non-algorithm-based allocation strategy.

The Expect-it study aims to accompany the development and clinical implementation process of a new algorithm for the management of expected difficult intubation. This new algorithm is designed to provide an evidence-based decision-making tool for a rational pre-choice of tracheal intubation techniques, anesthetized intubation by direct laryngoscopy (DL) or videolaryngoscopy (VL) or awake tracheal intubation (ATI). In the first study phase the status quo (clinical standard, non-algorithm-based decision-making) will be assessed (three-month period with an approximated case number of up to 600 patients). The Expect-it algorithm will be implemented thereafter. Between both study phases, the algorithm will be updated (based on the findings of the first phase), sensitivity and specificity of the clinical standard will be calculated, sample size will critically be appraised and readjusted (approximately 600 within at least three months), if appropriate. The second study phase is a confirmatory diagnostic accuracy study for the new algorithm with a single test study design, that aims to proof, if the new Expect-it algorithm is superior or at least non-inferior to the clinical standard, defined as superiority in either the specificity or sensitivity and non-inferiority in the other co-primary endpoint in each domain (ATI, DL, VL) (pre-planned preliminary analysis of the first study phase; IRB amendment 2021-10459_2-BO-ff, December 3, 2021). Sensitivity and specificity are considered co-primary endpoints. Study planning and conduction is in accordance with the Standards for Reporting Diagnostic accuracy studies (STARD) statement. The Expect-it study will further include two surveys among anesthetist in the study center in order to evaluate challenges and obstacles associated with the implementation process and possible clinical implications of the algorithm. An additional analysis will be performed to test a core data set for an 'anesthesia alert card'.

02

Conditions studied

  • Airway Management
  • Intubation, Intratracheal

Keywords

  • Laryngoscopy
  • Laryngoscopes
  • Diagnostic Techniques, Respiratory System
03

In context

Lead sponsor

Universitätsklinikum Hamburg-Eppendorf is the lead sponsor of 403 studies on the registry; 83 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Consecutive sampling: Adult patients that undergo ENT or OMS surgery in a tertiary care hospital who require tracheal intubation and consent to participate within two predefined study periods of at least 3 months.

Inclusion criteria

  • Patients undergoing ENT or OMS surgery that require general anesthesia with tracheal intubation (either DL, VL or ATI)
  • Age ≥ 18 years

Exclusion criteria

Exclusion Criteria:

  • Denial of consent
  • Planned intubation technique is not designated in the study protocol as it differs from either DL, VL, ATI (e.g. primary tracheotomy or rigid bronchoscopy)
05

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
1,282 participants (actual)
Patient registry
No

Groups and cohorts

  • Clinical standard (first study phase)

    Current clinical standard, non-algorithm-based decision-making (prior to implementation of the algorithm)

    Other: No intervention, observational study

  • Algorithm-based allocation (second study phase)

    New algorithm-based allocation to an intubation technique (after implementation of the algorithm)

    Other: No intervention, observational study

Interventions

  • OtherNo intervention, observational study

    Exposure of interest: clinical implementation of an algorithm

06

What researchers measure

Primary outcomes

  1. First phase: sensitivity and specificity (co-primary endpoints) of the clinical standard

    Clinical assessment

    Time frame: 3 months

  2. Second phase: sensitivity and specificity (co-primary endpoints) of 'ATI recommendation' by the algorithm vs. 'VL/DL'

    Clinical assessment

    Time frame: 3 months

  3. Second phase: sensitivity and specificity (co-primary endpoints) of 'DL recommendation' by the algorithm vs. 'VL/ATI'

    Clinical assessment

    Time frame: 3 months

  4. Second phase: sensitivity and specificity (co-primary endpoints) of 'VL recommendation' by the algorithm vs. 'DL/ATI'

    Clinical assessment

    Time frame: 3 months

Secondary outcomes

  1. Post-intubation recommendation for an intubation method

    Recommendation of the responsible anesthetist

    Time frame: 1 hour

  2. Post-intubation recommendation for an anesthesia alert card

    Recommendation of the responsible anesthetist

    Time frame: 1 hour

  3. Post-intubation diagnosis 'difficult intubation'

    Rating of the responsible anesthetist

    Time frame: 1 hour

  4. Post-intubation diagnosis 'difficult face-mask-ventilation'

    Rating of the responsible anesthetist

    Time frame: 1 hour

  5. Classification of intubation difficulty (VIDIAC classification)

    Rating between -1 and 5 points

    Time frame: 1 hour

  6. Best glottic view

    Grading according to 'Percentage of Glottis Opening' (POGO)

    Time frame: 1 hour

  7. Best glottic view

    Grading according to the Cormack Lehane classification (I-IV)

    Time frame: 1 hour

  8. First pass success rate

    Percentage of successful intubations with one attempt

    Time frame: 1 hour

  9. Overall success rate of the first choice technique

    Percentage of successful intubation without transition to another technique

    Time frame: 1 hour

  10. Number of attempts

    Total number of attempts until airway established

    Time frame: 1 hour

  11. Intubation time

    Time to successful tracheal intubation

    Time frame: 1 hour

  12. Lowest oxygen saturation

    Measured with pulse oxymetry during anesthesia induction

    Time frame: 1 hour

  13. Overall intubation difficulty, ease of intubation, quality of visualization

    Subjective ratings on visual analogue scales (0 to 100 with 0 being the best)

    Time frame: 1 hour

  14. Airway-related adverse events

    Laryngospasm, bronchospasm, larynx trauma, airway trauma, soft tissue trauma, oral bleeding, edema, dental damage, corticosteroid application, accidental esophageal intubation, aspiration, hypotension or hypoxia

    Time frame: 1 hour

  15. Patient discomfort, satisfaction, symptoms

    Clinical assessment during follow-up

    Time frame: 12 hours

  16. Clinical evaluation of a core dataset 'anesthesia alert card'

    Rating of various anesthetist

    Time frame: 10 months

  17. Quality of care of the current clinical standard and the effects of algorithm implementation

    Survey among anesthetist

    Time frame: 7 months

07

Study locations

1 site
  • University Medical Center Hamburg-Eppendorf
    Hamburg, 20246, Germany
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 2, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT04863846
Lead sponsor
Universitätsklinikum Hamburg-Eppendorf
Responsible party
Sponsor
First posted
Apr 28, 2021
Start date
May 1, 2021
Primary completion
Jan 29, 2022
Completion
Jan 29, 2022
Last update
Mar 2, 2022

Study contacts

Martin Petzoldt, MD
study chair · Universitätsklinikum Hamburg-Eppendorf
Antonia Zapf, PhD
study chair · Universitätsklinikum Hamburg-Eppendorf
Christian Zöllner, MD
study chair · Universitätsklinikum Hamburg-Eppendorf

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion